PressSeptember 27, 2021 Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders
PressSeptember 24, 2021 MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration
PressSeptember 20, 2021 Mindset Pharma Announces Further Preclinical Results for its 5-MeO-DMT-Inspired Drug Candidate.
PressSeptember 20, 2021 Delic to Acquire Ketamine Wellness Centers Inc, Becoming Largest Psychedelic Wellness Chain in United States
PressSeptember 16, 2021 COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs
PressSeptember 16, 2021 Awakn Life Sciences to Acquire Leading Ketamine-assisted Psychotherapy Clinic in Norway
PressSeptember 15, 2021 Nova Mentis Life Science Applies to US FDA for Psilocybin Orphan Drug Designation Fragile X Syndrome Treatment
PressSeptember 15, 2021 Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment resistant depression
PressSeptember 14, 2021 Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine
PressSeptember 13, 2021 PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022
PressSeptember 9, 2021 Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104
PressSeptember 8, 2021 Journey Colab secures $12M Series A funding for Phase 1 trial of Mescaline HCl, JOUR-001, for treatment of Alcohol Use Disorder
PressSeptember 7, 2021 Field Trip Health opens Europe’s first psychedelic therapy healthcare facility
PressSeptember 3, 2021 Filament Health Files 20th Patent Application Including Three International Pct Applications
PressSeptember 3, 2021 Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers
PressSeptember 2, 2021 MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes
